Polypoidal choroidal vasculopathy: Pearls in diagnosis and management
暂无分享,去创建一个
Muna Bhende | Charu Gupta | Sundaram Natarajan | Anand Rajendran | Rupak Biswas | Jay Sheth | S. Natarajan | M. Bhende | P. Sen | A. Banker | R. Narayanan | George J. Manayath | Giridhar Anantharaman | Parveen Sen | Giridhar Anantharaman | Raja Narayanan | George Manayath | Alay Banker | J. Sheth | A. Rajendran | C. Gupta | R. Biswas
[1] S. Sengupta,et al. Sensitivity and Specificity of Spectral-Domain Optical Coherence Tomography in Detecting Idiopathic Polypoidal Choroidal Vasculopathy. , 2014, American journal of ophthalmology.
[2] Y. Oshima,et al. INITIAL VERSUS DELAYED PHOTODYNAMIC THERAPY IN COMBINATION WITH RANIBIZUMAB FOR TREATMENT OF POLYPOIDAL CHOROIDAL VASCULOPATHY: The Fujisan Study , 2015, Retina.
[3] Michael D. Ober,et al. SELECTIVE PHOTODYNAMIC THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH POLYPOIDAL CHOROIDAL NEOVASCULARIZATION , 2007, Retina.
[4] F. Shiraga,et al. Two-year results of reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy. , 2013, American journal of ophthalmology.
[5] M. Matsumura,et al. Polypoidal choroidal vasculopathy: natural history. , 2002, American journal of ophthalmology.
[6] P. Ruamviboonsuk,et al. POLYPOIDAL CHOROIDAL VASCULOPATHY: Evidence-Based Guidelines for Clinical Diagnosis and Treatment , 2013, Retina.
[7] Akio Oishi,et al. Choroidal thickness, vascular hyperpermeability, and complement factor H in age-related macular degeneration and polypoidal choroidal vasculopathy. , 2012, Investigative ophthalmology & visual science.
[8] Dong Kyu Lee,et al. Aflibercept Treatment for Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy Refractory to Anti-vascular Endothelial Growth Factor , 2015, Korean journal of ophthalmology : KJO.
[9] Y. Tano,et al. Angiographic lesion of polypoidal choroidal vasculopathy on indocyanine green and fluorescein angiography , 2007, Graefe's Archive for Clinical and Experimental Ophthalmology.
[10] M. Moschos,et al. Polypoidal choroidal vasculopathy and exudative age-related macular degeneration in Greek population , 2004, Eye.
[11] Y. Kurimoto,et al. Comparative Assessment of Photodynamic Therapy for Typical Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy: A Multicenter Study in Hyogo Prefecture, Japan , 2009, Ophthalmologica.
[12] A. Tsujikawa,et al. Indocyanine green angiography: guided photodynamic therapy for polypoidal choroidal vasculopathy. , 2007, American journal of ophthalmology.
[13] K. Fujita,et al. Role of Photodynamic Therapy in Polypoidal Choroidal Vasculopathy , 2007, Japanese Journal of Ophthalmology.
[14] Tien Yin Wong,et al. Argon laser with and without anti-vascular endothelial growth factor therapy for extrafoveal polypoidal choroidal vasculopathy. , 2013, American journal of ophthalmology.
[15] LAPTOP study: a 24-month trial of verteporfin versus ranibizumab for polypoidal choroidal vasculopathy. , 2014, Ophthalmology.
[16] M. Mandai,et al. Laser photocoagulation of indocyanine green angiographically identified feeder vessels to idiopathic polypoidal choroidal vasculopathy. , 2004, American journal of ophthalmology.
[17] A. Okada,et al. Clinical Features of Polypoidal Choroidal Vasculopathy and Visual Outcomes in the Absence of Classic Choroidal Neovascularization , 2009, Ophthalmologica.
[18] T. Wakabayashi,et al. Efficacy of intravitreal bevacizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy. , 2010, American journal of ophthalmology.
[19] A. Negi,et al. Different transitions of multifocal electroretinogram recordings between patients with age-related macular degeneration and polypoidal choroidal vasculopathy after photodynamic therapy , 2006, British Journal of Ophthalmology.
[20] Paisan Ruamviboonsuk,et al. The fundoscopic features for differentiation between polypoidal choroidal vasculopathy and choroidal neovascularization from age-related macular degeneration. , 2005, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.
[21] E. Souied,et al. Toward a specific classification of polypoidal choroidal vasculopathy: idiopathic disease or subtype of age-related macular degeneration. , 2015, Investigative ophthalmology & visual science.
[22] Se Woong Kang,et al. Choroidal thickness in polypoidal choroidal vasculopathy and exudative age-related macular degeneration. , 2011, Ophthalmology.
[23] T. Hikichi,et al. Improvement of angiographic findings of polypoidal choroidal vasculopathy after intravitreal injection of ranibizumab monthly for 3 months. , 2010, American journal of ophthalmology.
[24] U. Schmidt-Erfurth,et al. Influence of treatment parameters on selectivity of verteporfin therapy. , 2006, Investigative ophthalmology & visual science.
[25] B. Lafaut,et al. Polypoidal choroidal vasculopathy in Caucasians , 2000, Graefe's Archive for Clinical and Experimental Ophthalmology.
[26] I. Maruko,et al. Clinical characteristics of exudative age-related macular degeneration in Japanese patients. , 2007, American journal of ophthalmology.
[27] T. Lim,et al. IMPROVED SPECIFICITY OF POLYPOIDAL CHOROIDAL VASCULOPATHY DIAGNOSIS USING A MODIFIED EVEREST CRITERIA , 2015, Retina.
[28] S. C. Lee,et al. Incidence and clinical patterns of polypoidal choroidal vasculopathy in Korean patients , 2008, Japanese Journal of Ophthalmology.
[29] Y. Tano,et al. Marked vascular changes of polypoidal choroidal vasculopathy after photodynamic therapy , 2008, British Journal of Ophthalmology.
[30] T. Desmettre,et al. Fluorescence properties and metabolic features of indocyanine green (ICG) as related to angiography. , 2000, Survey of ophthalmology.
[31] M. Mauget-Faÿsse,et al. Photodynamic Therapy with Verteporfin in the Treatment of Exudative Idiopathic Polypoidal Choroidal Vasculopathy , 2006, European journal of ophthalmology.
[32] J. Cunha-Vaz,et al. Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.
[33] Photodynamic therapy for polypoidal choroidal vasculopathy. , 2010, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[34] Y. Tano,et al. Long-term follow-up of polypoidal choroidal vasculopathy after photodynamic therapy with verteporfin , 2007, Graefe's Archive for Clinical and Experimental Ophthalmology.
[35] I. Yeo,et al. Argon laser photocoagulation for the treatment of polypoidal choroidal vasculopathy , 2009, Eye.
[36] Shanshan Yu,et al. DISTINGUISHING POLYPOIDAL CHOROIDAL VASCULOPATHY FROM TYPICAL NEOVASCULAR AGE-RELATED MACULAR DEGENERATION BASED ON SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY , 2016, Retina.
[37] C. Puliafito,et al. Photodynamic therapy of polypoidal choroidal vasculopathy. , 2003, Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.
[38] A. Tsujikawa,et al. Two-year results of photodynamic therapy for polypoidal choroidal vasculopathy. , 2008, American journal of ophthalmology.
[39] T. Lim,et al. A novel classification of the vascular patterns of polypoidal choroidal vasculopathy and its relation to clinical outcomes , 2014, British Journal of Ophthalmology.
[40] D. Marcus,et al. High-dose ranibizumab monotherapy for neovascular polypoidal choroidal vasculopathy in a predominantly non-Asian population , 2015, Eye.
[41] Jong Woo Kim,et al. Short-term Effectiveness of Intravitreal Bevacizumab vs. Ranibizumab Injections for Patients with Polypoidal Choroidal Vasculopathy , 2012, Korean journal of ophthalmology : KJO.
[42] Augustinus Laude,et al. Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: Same or different disease? , 2010, Progress in Retinal and Eye Research.
[43] H. Koizumi,et al. One-Year Results of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy. , 2015, Ophthalmology.
[44] 山下 彩奈. One-year results of reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy , 2010 .
[45] S. Kishi,et al. Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for polypoidal choroidal vasculopathy. , 2010, American journal of ophthalmology.
[46] L. Yannuzzi,et al. Polypoidal choroidal vasculopathy: a review. , 2010, Survey of ophthalmology.
[47] M. Mandai,et al. Characteristics of fine vascular network pattern associated with recurrence of polypoidal choroidal vasculopathy , 2011, Eye.
[48] M. Yuzawa,et al. A study of laser photocoagulation for polypoidal choroidal vasculopathy. , 2003, Japanese journal of ophthalmology.
[49] J. Slakter,et al. Digital indocyanine-green videoangiography of occult choroidal neovascularization. , 1994, Ophthalmology.
[50] M. Mandai,et al. HEMORRHAGIC COMPLICATIONS AFTER PHOTODYNAMIC THERAPY FOR POLYPOIDAL CHOROIDAL VASCULOPATHY , 2007, Retina.
[51] H. Imaizumi,et al. Photodynamic Therapy for Age-Related Macular Degeneration in Japanese Patients: Results After One Year , 2007, Japanese Journal of Ophthalmology.
[52] K. Kadonosono,et al. SHORT-TERM EFFICACY OF INTRAVITREAL AFLIBERCEPT IN TREATMENT-NAIVE PATIENTS WITH POLYPOIDAL CHOROIDAL VASCULOPATHY , 2014, Retina.
[53] J. Chhablani,et al. Ziv-aflibercept: a novel option for the treatment of polypoidal choroidal vasculopathy , 2015, BMJ Case Reports.
[54] T. Lai,et al. Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series. , 2004, Ophthalmology.
[55] S. W. Kang,et al. Polypoidal choroidal vasculopathy and late geographic hyperfluorescence on indocyanine green angiography , 2009, British Journal of Ophthalmology.
[56] Y. Tano,et al. One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients. , 2010, Ophthalmology.
[57] N. Ghazi,et al. Spectral-domain optical coherence tomography findings in polypoidal choroidal vasculopathy suggest a type 1 neovascular growth pattern , 2014, Clinical ophthalmology.
[58] M. Mandai,et al. Central retinal sensitivity measured with the micro perimeter 1 after photodynamic therapy for polypoidal choroidal vasculopathy. , 2007, American journal of ophthalmology.
[59] I. Mantel,et al. Peripheral exudative hemorrhagic chorioretinopathy: polypoidal choroidal vasculopathy and hemodynamic modifications. , 2012, American journal of ophthalmology.
[60] K. Nishida,et al. ONE-YEAR RESULTS OF INTRAVITREAL AFLIBERCEPT FOR POLYPOIDAL CHOROIDAL VASCULOPATHY , 2016, Retina.
[61] M. Yuzawa,et al. Long-Term Results of Photodynamic Therapy of Polypoidal Choroidal Vasculopathy , 2008, Retina.
[62] Akira Negi,et al. Polypoidal Choroidal Vasculopathy: Clinical Features and Genetic Predisposition , 2013, Ophthalmologica.
[63] Y. Tano,et al. Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy , 2007, British Journal of Ophthalmology.
[64] M. Matsumura,et al. Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics. , 2003, Archives of ophthalmology.
[65] T. Iida,et al. Photodynamic therapy with verteporfin for age-related macular degeneration or polypoidal choroidal vasculopathy: comparison of the presence of serous retinal pigment epithelial detachment , 2008, British Journal of Ophthalmology.
[66] M. Tadarati,et al. Photodynamic therapy combined with ranibizumab for polypoidal choroidal vasculopathy: results of a 1-year preliminary study , 2010, British Journal of Ophthalmology.
[67] Shih-Jen Chen,et al. Comparison of the effect of reduced‐fluence photodynamic therapy with intravitreal bevacizumab and standard‐fluence alone for polypoidal choroidal vasculopathy , 2014, Journal of the Chinese Medical Association : JCMA.
[68] L. Yannuzzi,et al. POLYPOIDAL CHOROIDAL VASCULOPATHY IN ITALY , 2001, Retina.
[69] J. Slakter,et al. TREATMENT OF POLYPOIDAL CHOROIDAL VASCULOPATHY WITH PHOTODYNAMIC THERAPY , 2002, Retina.
[70] G. Coscas,et al. Exudative idiopathic polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin. , 2002, American journal of ophthalmology.
[71] W. Lee,et al. Photodynamic therapy for polypoidal choroidal vasculopathy: Vaso-occlusive effect on the branching vascular network and origin of recurrence , 2008, Japanese Journal of Ophthalmology.
[72] L A Yannuzzi,et al. IDIOPATHIC POLYPOIDAL CHOROIDAL VASCULOPATHY (IPCV) , 1990, Retina.
[73] F. Wen,et al. Subtype lesions of neovascular age-related macular degeneration in Chinese patients , 2007, Graefe's Archive for Clinical and Experimental Ophthalmology.
[74] E. Neoh,et al. Polypoidal choroidal vasculopathy in Chinese patients , 2002, The British journal of ophthalmology.
[75] S. Kishi,et al. TOMOGRAPHIC FEATURES OF BRANCHING VASCULAR NETWORKS IN POLYPOIDAL CHOROIDAL VASCULOPATHY , 2007, Retina.
[76] Tock Han Lim,et al. EVEREST study report 2: imaging and grading protocol, and baseline characteristics of a randomised controlled trial of polypoidal choroidal vasculopathy , 2015, British Journal of Ophthalmology.
[77] Wen-Chuan Wu,et al. Polypoidal choroidal vasculopathy in Taiwanese patients. , 2009, Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.
[78] Mahesh Gopalakrishnan,et al. Clinical features, management and visual outcome of polypoidal choroidal vasculopathy in Indian patients , 2010, Indian journal of ophthalmology.
[79] Won Ki Lee,et al. Efficacy and Safety of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: A Randomized Clinical Trial , 2017, JAMA ophthalmology.
[80] Won Ki Lee,et al. EVEREST STUDY: Efficacy and Safety of Verteporfin Photodynamic Therapy in Combination with Ranibizumab or Alone Versus Ranibizumab Monotherapy in Patients with Symptomatic Macular Polypoidal Choroidal Vasculopathy , 2012, Retina.
[81] T. Sekiryu,et al. SWITCHING TO INTRAVITREAL AFLIBERCEPT INJECTION FOR POLYPOIDAL CHOROIDAL VASCULOPATHY REFRACTORY TO RANIBIZUMAB , 2014, Retina.